BWM
DFTX

Bullock Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Bullock Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4K Hold
907
– – 0.02% 304
2026
Q1 		$18.7K Sell
907
-287
-24% -$4.87K 0.01% 351
2025
Q4 		$16K Hold
1,194
– – 0.01% 361
2025
Q3 		$14.7K Hold
1,194
– – 0.01% 375
2025
Q2 		$7.98K Hold
1,194
– – ﹤0.01% 421
2025
Q1 		$6.62K Hold
1,194
– – ﹤0.01% 426
2024
Q4 		$8.31K Hold
1,194
– – ﹤0.01% 411
2024
Q3 		$6.72K Hold
1,194
– – ﹤0.01% 413
2024
Q2 		$8.44K Buy
+1,194
New +$10.4K 0.01% 370

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bullock Wealth Management's DFTX Position: Q2 2026 in Review

Bullock Wealth Management held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 907 shares worth $39.4K. The position accounts for 0.02% of the portfolio, ranked #304.

Bullock Wealth Management first reported a position in DFTX in Q2 2024 and has held it in 9 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Bullock Wealth Management held 907 shares of Definium Therapeutics worth $39.4K as of Q2 2026.
  • Bullock Wealth Management left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up 0.02% of Bullock Wealth Management's portfolio in Q2 2026, its #304 holding.
  • Bullock Wealth Management first reported a position in Definium Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.